Follow The Filings

TFX Teleflex Incorporated

Health Care, filed as TELEFLEX INCORPORATED (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 3 managers in 2026 Q2

  • 3 Owners
  • Max 4.9%
  • $356M
  • 3 reduce

In 2026 Q2 Abrams Bison, Seth Klarman, and Richard Pzena trimmed Teleflex.

Who owns this now

Largest portfolio weights among holders, up to 4.9% (Abrams Bison, Abrams Bison Investments). Not free-float ownership.

  1. Abrams Bison Reduce 4.9%
  2. Seth Klarman Reduce 3.3%
  3. Richard Pzena Reduce 0.22%

Who owns TFX

Sorted by value, long equity only, as of 2026 Q2.

History
Seth Klarman, Baupost Group 3.3%, was 3.7% Reduce −11.7% 1,409,000 $179M History
Abrams Bison, Abrams Bison Investments 4.9%, was 5.2% Reduce −20.7% 793,000 $101M History
Richard Pzena, Pzena Investment Management 0.22%, was 0.27% Reduce −13.7% 603,206 $76M History

3 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by TFX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TFX insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 23 stock grants and 10 share withholdings for taxes.

Congress

2 members of Congress traded TFX in the last three years: 1 buy and 2 sales. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Jul 22, 2025 filed Aug 13, 2025
  2. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jul 16, 2025 filed Aug 13, 2025
  3. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K Feb 25, 2025 filed Mar 27, 2025

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K/A 9.01 Filing Doc
8-K 2.01,7.01,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.97B $3.05B $1.99B
Gross profit $1.65B $1.7B $1.12B
Gross margin * 55.4% 55.9% 56.2%
Net income $356.33M $69.68M -$905.64M
Net margin * 12.0% 2.3% -45.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.41B $1.47B $1.94B
Total non-current assets * $6.13B $5.63B $5.01B
Total assets $7.53B $7.1B $6.95B
Total current liabilities $606.74M $649.36M $762.03M
Total non-current liabilities * $2.48B $2.17B $3.06B
Total equity $4.44B $4.28B $3.12B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $511.68M $638.26M $96.68M
Cash from financing $38.54M -$421.92M $611.54M
Net change in cash -$69.19M $104.8M $126.2M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.